Redox Dysregulation in the Pathophysiology of Schizophrenia and Bipolar Disorder: Insights from Animal Models

被引:94
|
作者
Kulak, Anita [1 ]
Steullet, Pascal [1 ]
Cabungcal, Jan-Harry [1 ]
Werge, Thomas [2 ]
Ingason, Andres [2 ]
Cuenod, Michel [1 ]
Do, Kim Quang [1 ]
机构
[1] Univ Lausanne Hosp, Ctr Psychiat Neurosci, Dept Psychiat, Prilly, Switzerland
[2] Copenhagen Univ Hosp, Res Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, iPSYCH, Roskilde, Denmark
基金
瑞士国家科学基金会;
关键词
N-ACETYL-CYSTEINE; LIGASE MODIFIER SUBUNIT; MAGNETIC-RESONANCE-SPECTROSCOPY; GLUTATHIONE-DEFICIENT MICE; DOPAMINE UPTAKE INHIBITION; ANTERIOR CINGULATE CORTEX; PITUITARY-ADRENAL AXIS; TERM SPATIAL MEMORY; PREFRONTAL CORTEX; PREPULSE INHIBITION;
D O I
10.1089/ars.2012.4858
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Schizophrenia (SZ) and bipolar disorder (BD) are classified as two distinct diseases. However, accumulating evidence shows that both disorders share genetic, pathological, and epidemiological characteristics. Based on genetic and functional findings, redox dysregulation due to an imbalance between pro-oxidants and antioxidant defense mechanisms has been proposed as a risk factor contributing to their pathophysiology. Recent Advances: Altered antioxidant systems and signs of increased oxidative stress are observed in peripheral tissues and brains of SZ and BD patients, including abnormal prefrontal levels of glutathione (GSH), the major cellular redox regulator and antioxidant. Here we review experimental data from rodent models demonstrating that permanent as well as transient GSH deficit results in behavioral, morphological, electrophysiological, and neurochemical alterations analogous to pathologies observed in patients. Mice with GSH deficit display increased stress reactivity, altered social behavior, impaired prepulse inhibition, and exaggerated locomotor responses to psychostimulant injection. These behavioral changes are accompanied by N-methyl-D-aspartate receptor hypofunction, elevated glutamate levels, impairment of parvalbumin GABA interneurons, abnormal neuronal synchronization, altered dopamine neurotransmission, and deficient myelination. Critical Issues: Treatment with the GSH precursor and antioxidant N-acetylcysteine normalizes some of those deficits in mice, but also improves SZ and BD symptoms when given as adjunct to antipsychotic medication. Future Directions: These data demonstrate the usefulness of GSH-deficient rodent models to identify the mechanisms by which a redox imbalance could contribute to the development of SZ and BD pathophysiologies, and to develop novel therapeutic approaches based on antioxidant and redox regulator compounds. Antioxid. Redox Signal. 18, 1428-1443.
引用
收藏
页码:1428 / 1443
页数:16
相关论文
共 50 条
  • [1] A Role for Glutathione in the Pathophysiology of Bipolar Disorder and Schizophrenia? Animal Models and Relevance to Clinical Practice
    Dean, O. M.
    van den Buuse, M.
    Bush, A. I.
    Copolov, D. L.
    Ng, F.
    Dodd, S.
    Berk, M.
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (23) : 2965 - 2976
  • [2] Animal models for bipolar disorder: from bedside to the cage
    Beyer, Dominik K. E.
    Freund, Nadja
    INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2017, 5
  • [3] Insights into myelin dysfunction in schizophrenia and bipolar disorder
    Valdes-Tovar, Marcela
    Rodriguez-Ramirez, Alejandra Monserrat
    Rodriguez-Cardenas, Leslye
    Sotelo-Ramirez, Carlo E.
    Camarena, Beatriz
    Sanabrais-Jimenez, Marco Antonio
    Solis-Chagoyan, Hector
    Argueta, Jesus
    Lopez-Riquelme, German Octavio
    WORLD JOURNAL OF PSYCHIATRY, 2022, 12 (02): : 264 - 285
  • [4] Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models
    Perrottelli, Andrea
    Marzocchi, Francesco Flavio
    Caporusso, Edoardo
    Giordano, Giulia Maria
    Giuliani, Luigi
    Melillo, Antonio
    Pezzella, Pasquale
    Bucci, Paola
    Mucci, Armida
    Galderisi, Silvana
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2024, 49 (02): : E109 - E125
  • [5] Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?
    Steullet, P.
    Cabungcal, J. H.
    Monin, A.
    Dwir, D.
    O'Donnell, P.
    Cuenod, M.
    Do, K. Q.
    SCHIZOPHRENIA RESEARCH, 2016, 176 (01) : 41 - 51
  • [6] Actin Cytoskeleton Dysregulation in Schizophrenia and Bipolar Disorder: Relevance to Dendritic Pathology
    Konopaske, Glenn T.
    Subburaju, Sivan
    Coyle, Joseph T.
    Benes, Francine M.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 77S - 77S
  • [7] New insights on nitric oxide: Focus on animal models of schizophrenia
    Morales-Medina, Julio Cesar
    Aguilar-Alonso, Patricia
    Di Cerbo, Alessandro
    Iannitti, Tommaso
    Flores, Gonzalo
    BEHAVIOURAL BRAIN RESEARCH, 2021, 409
  • [8] Adolescent Onset of Cortical Disinhibition in Schizophrenia: Insights From Animal Models
    O'Donnell, Patricio
    SCHIZOPHRENIA BULLETIN, 2011, 37 (03) : 484 - 492
  • [9] Developing translational animal models for symptoms of schizophrenia or bipolar mania
    Mark A. Geyer
    Neurotoxicity Research, 2008, 14 : 71 - 78
  • [10] Developing translational animal models for symptoms of schizophrenia or bipolar mania
    Geyer, Mark A.
    NEUROTOXICITY RESEARCH, 2008, 14 (01) : 71 - 78